Prognostic Value of the 6-Minute Walk Test in Patients With Severe Aortic Stenosis
The 6MWD is a reliable prognostic marker for patients with severe AS, regardless of initial treatment strategy.
Authors
- Norio Kanamori (ORCID: https://orcid.org/0000-0002-3986-192X)
- Shin Watanabe (ORCID: https://orcid.org/0000-0001-8526-3712)
- Mitsuru Ishii (ORCID: https://orcid.org/0000-0002-8686-3733)
- Takeshi Aoyama (ORCID: https://orcid.org/0000-0002-8544-9303)
- Tomohiko Taniguchi (ORCID: https://orcid.org/0000-0002-4999-3432)
- Ryosuke Murai (ORCID: https://orcid.org/0000-0002-7866-0266)
- Yasutaka Inuzuka (ORCID: https://orcid.org/0000-0002-2069-7963)
- Kiyonori Togi (ORCID: https://orcid.org/0000-0003-1081-3163)
- Yasuaki Takeji (ORCID: https://orcid.org/0000-0001-7101-0351)
- Makoto Miyake (ORCID: https://orcid.org/0000-0002-9519-6637)
- Ryusuke Nishikawa (ORCID: https://orcid.org/0000-0001-5038-1292)
- Fumiko Nakazeki (ORCID: https://orcid.org/0000-0001-6280-5742)
- Kohei Osakada (ORCID: https://orcid.org/0000-0002-8715-7080)
- Tatsuhiko Komiya (ORCID: https://orcid.org/0000-0003-3807-6724)
- Shunsuke Usami (ORCID: https://orcid.org/0000-0003-2605-5600)
- Hiroyuki Tabata (ORCID: https://orcid.org/0009-0008-1939-9185)
- Kenji Minatoya (ORCID: https://orcid.org/0000-0001-7828-9762)
- Shojiro Tatsushima
- Kenji Andò (ORCID: https://orcid.org/0000-0003-0699-4248)
- Hiroshi Tsuneyoshi
- Yusuke Yoshikawa (ORCID: https://orcid.org/0000-0001-8082-2036)
- Hiroki Shiomi (ORCID: https://orcid.org/0000-0001-7234-023X)
- Hirotoshi Watanabe (ORCID: https://orcid.org/0000-0002-9443-5915)
- Moriaki Inoko (ORCID: https://orcid.org/0000-0003-1388-4899)
- Kazuya Nagao (ORCID: https://orcid.org/0000-0002-5043-8778)
- Kenji Nakatsuma (ORCID: https://orcid.org/0000-0001-8894-7538)
- Masayasu Izuhara (ORCID: https://orcid.org/0009-0007-1521-5142)
- Takeshi Morimoto (ORCID: https://orcid.org/0000-0002-6844-739X)
- Mamoru Toyofuku
- Nobuhisa Ohno
- Masashi Amano (ORCID: https://orcid.org/0000-0003-4095-1567)
- Takeshi Kitai (ORCID: https://orcid.org/0000-0003-2416-5865)
- Koichiro Murata (ORCID: https://orcid.org/0009-0008-9824-6215)
- Masahiro Kimura (ORCID: https://orcid.org/0000-0002-9790-4609)
- Shinichi Shirai (ORCID: https://orcid.org/0000-0002-4764-8205)
- Takanari Fujita
- Hiroyuki Nakayama (ORCID: https://orcid.org/0000-0002-7355-7112)
- Ko Yamamoto
- Yuki Obayashi
- Masanao Nakai
- Takeshi Kimura
- Tomohisa Tada (ORCID: https://orcid.org/0000-0003-1666-551X)
- Koh Ono
Institutions
- Kanazawa University (JP)
- Kyoto University (JP)
- Tenri Hospital (JP)
- Kyoto Medical Center (JP)
- Kurashiki Central Hospital (JP)
- Kishiwada City Hospital (JP)
- National Cerebral and Cardiovascular Center (JP)
- Kansai Electric Power Hospital (JP)
- Shimada Municipal Hospital (JP)
- Shizuoka City Hospital (JP)
- Otsu Red Cross Hospital (JP)
- Shizuoka General Hospital (JP)
- Hyogo Prefectural Amagasaki General Medical Center (JP)
- Mitsubishi Kyoto Hospital (JP)
- Koto Hospital (JP)
- Osaka Red Cross Hospital (JP)
- Japanese Red Cross Society Wakayama Medical Center (JP)
- Shiga Medical Center (JP)
- Kitano Hospital (JP)
- Kokura Memorial Hospital (JP)
- Kobe City Medical Center General Hospital (JP)
- Municipal Hirakata City Hospital (JP)
- Hyogo University (JP)
- Kindai University (JP)
Publication Details
- Journal
- Circulation Journal
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1253/circj.cj-25-0056
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Sanofi
- Edwards Lifesciences
- CSL Behring
- Boston Scientific Corporation
- Japan Lifeline
- Kowa Company
- Nipro
- Abiomed
- Eisai
- Astellas Pharma
- Otsuka Pharmaceutical
- Mitsubishi Tanabe Pharma Corporation
- Ono Pharmaceutical
- Novartis Pharma
- Chugai Pharmaceutical
- Abbott Vascular
- Japan Society for the Promotion of Science
- Daiichi Sankyo Europe